News

PDL BioPharma Announces First Quarter 2017 Financial Results

INCLINE VILLAGE, Nev., May 3, 2017 /PRNewswire/ — PDL BioPharma, Inc. (PDL or the Company) (NASDAQ: PDLI) today
reported financial results for the first quarter ended March 31, 2017 including:

  • Total revenues of $45.4 million for the three months ended March 31, 2017.
  • GAAP diluted EPS of $0.04 for the three months ended March 31, 2017.
  • GAAP net income attributable to PDL’s shareholders of $7.2 million for the three months ended March 31, 2017.
  • Non-GAAP net income attributable to PDL’s shareholders of $13.2 million for the three months ended March 31, 2017. A full reconciliation of all components of the GAAP to non-GAAP financial results can be found in Table 4 at the end of the release.

Read Full Text

Leave a Reply

Your email address will not be published. Required fields are marked *